Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bright Minds Biosciences | CSE | Healthcare | Biotechnology & Medical Research | CAD 306.12M | -89x | -1.72 | CAD 43.80 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cybin | CBOE Canada | Healthcare | Biotechnology & Medical Research | CAD 284.11M | -1.6x | -0.16 | CAD 14.15 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fennec Pharma | Toronto | Healthcare | Biotechnology & Medical Research | CAD 256.13M | -154.1x | -1.6 | CAD 9.30 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NervGen Pharma | TSXV | Healthcare | Biotechnology & Medical Research | CAD 198.27M | -6.8x | 0.74 | CAD 2.82 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ME Therapeutics Holdings | CSE | Healthcare | Biotechnology & Medical Research | CAD 176.33M | CAD 7 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
ZEN Graphene | TSXV | Healthcare | Biotechnology & Medical Research | CAD 167.54M | -15.3x | -1.24 | CAD 1.61 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cardiol Therapeutics | Toronto | Healthcare | Biotechnology & Medical Research | CAD 155.86M | -3.5x | 0.21 | CAD 1.91 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eupraxia Pharmaceuticals | Toronto | Healthcare | Biotechnology & Medical Research | CAD 151.40M | -3.5x | -0.17 | CAD 4.25 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medicenna | Toronto | Healthcare | Biotechnology & Medical Research | CAD 101.68M | -3.5x | 0.03 | CAD 1.30 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Satellos Bioscience | Toronto | Healthcare | Biotechnology & Medical Research | CAD 96.75M | -3.4x | 0.17 | CAD 0.85 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.4% Upside | Upgrade to Pro+ | |
Oncolytics Biotech | Toronto | Healthcare | Biotechnology & Medical Research | CAD 80.93M | -2.8x | -0.11 | CAD 1.05 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MustGrow Biologics | TSXV | Healthcare | Biotechnology & Medical Research | CAD 72.81M | -372.5x | -3.29 | CAD 1.41 | 9.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Microbix Biosystems Inc. | Toronto | Healthcare | Biotechnology & Medical Research | CAD 66.44M | 18.9x | 0 | CAD 0.49 | 4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Zyus Life Sciences | TSXV | Healthcare | Biotechnology & Medical Research | CAD 62.46M | -1.6x | 0.46 | CAD 0.84 | 7.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sharp Therapeutics | TSXV | Healthcare | Biotechnology & Medical Research | CAD 62.09M | -0x | CAD 2.20 | 109.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Defence Therapeutics | CSE | Healthcare | Biotechnology & Medical Research | CAD 55.43M | 0.08 | CAD 1.15 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Defence Therapeutics | CSE | Healthcare | Biotechnology & Medical Research | CAD 55.43M | 0.08 | CAD 1.15 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Helix BioPharma Corp. | Toronto | Healthcare | Biotechnology & Medical Research | CAD 48.04M | -4.8x | 0.13 | CAD 0.98 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
KDA Group | TSXV | Healthcare | Biotechnology & Medical Research | CAD 47.37M | -5.8x | 0.05 | CAD 0.26 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hemostemix Inc | TSXV | Healthcare | Biotechnology & Medical Research | CAD 44.30M | -14.6x | -0.61 | CAD 0.31 | -18.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NurExone Biologic | TSXV | Healthcare | Biotechnology & Medical Research | CAD 38.99M | -7.2x | -0.34 | CAD 0.55 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Thiogenesis Therapeutics | TSXV | Healthcare | Biotechnology & Medical Research | CAD 30.95M | -7x | 4.34 | CAD 0.68 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sona Nanotech | CSE | Healthcare | Biotechnology & Medical Research | CAD 30.16M | -9.4x | 0.05 | CAD 0.27 | -6.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Avicanna | Toronto | Healthcare | Biotechnology & Medical Research | CAD 29.21M | -4.6x | -0.09 | CAD 0.26 | -3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rakovina Therapeutics | TSXV | Healthcare | Biotechnology & Medical Research | CAD 27.36M | -2.2x | 0.44 | CAD 0.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Briacell Therapeutics | Toronto | Healthcare | Biotechnology & Medical Research | CAD 25.99M | -0.4x | -0.02 | CAD 8.82 | 15.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharmala Biotech Holdings | CSE | Healthcare | Biotechnology & Medical Research | CAD 22.76M | CAD 0.22 | 10% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
BetterLife Pharma Inc | CSE | Healthcare | Biotechnology & Medical Research | CAD 21.31M | -0.6x | 0.09 | CAD 0.13 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BetterLife Pharma Inc | CSE | Healthcare | Biotechnology & Medical Research | CAD 21.31M | -0.6x | 0.09 | CAD 0.13 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioMark Diagnostics Inc | CSE | Healthcare | Biotechnology & Medical Research | CAD 17.54M | -10.2x | 0.3 | CAD 0.22 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biovaxys Technology | CSE | Healthcare | Biotechnology & Medical Research | CAD 17.12M | -0.06 | CAD 0.06 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Numinus Wellness Inc | Toronto | Healthcare | Biotechnology & Medical Research | CAD 16.12M | -0.5x | -0.01 | CAD 0.05 | 57.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
COSCIENS Biopharma | Toronto | Healthcare | Biotechnology & Medical Research | CAD 14.99M | -0.2x | 0.02 | CAD 3.99 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sirona Biochem Corp | TSXV | Healthcare | Biotechnology & Medical Research | CAD 14.50M | -5.5x | 0.39 | CAD 0.05 | 20% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Resverlogix Corp. | Toronto | Healthcare | Biotechnology & Medical Research | CAD 14.09M | -0.9x | -0.06 | CAD 0.05 | -18.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Glow Lifetech | CSE | Healthcare | Biotechnology & Medical Research | CAD 11.86M | -0.18 | CAD 0.07 | -6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Glow Lifetech | CSE | Healthcare | Biotechnology & Medical Research | CAD 11.86M | -0.18 | CAD 0.07 | -6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Telo Genomics | TSXV | Healthcare | Biotechnology & Medical Research | CAD 10.81M | -4x | -0.25 | CAD 0.14 | -6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Innovotech | TSXV | Healthcare | Biotechnology & Medical Research | CAD 9.45M | -27.9x | 1.72 | CAD 0.19 | -5.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medicure | TSXV | Healthcare | Biotechnology & Medical Research | CAD 8.56M | -4.2x | 0.01 | CAD 0.82 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Quantum BioPharma | CSE | Healthcare | Biotechnology & Medical Research | CAD 8.06M | -0.2x | -0.01 | CAD 4.20 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Marvel Biosciences | TSXV | Healthcare | Biotechnology & Medical Research | CAD 6.94M | -5x | -0.1 | CAD 0.16 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Principal Tech | TSXV | Healthcare | Biotechnology & Medical Research | CAD 6.20M | -2.8x | 0.28 | CAD 0.17 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Asep Medical Holdings | CSE | Healthcare | Biotechnology & Medical Research | CAD 5.76M | -1.1x | -0.02 | CAD 0.08 | 66.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Asep Medical Holdings | CBOE Canada | Healthcare | Biotechnology & Medical Research | CAD 5.76M | -1.1x | -0.02 | CAD 0.08 | 66.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MYND Life Sciences | CSE | Healthcare | Biotechnology & Medical Research | CAD 5.02M | -3.4x | -0.12 | CAD 0.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
StageZero Life Sciences | Toronto | Healthcare | Biotechnology & Medical Research | CAD 4.94M | -0.2x | CAD 0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
XORTX Therapeutics | TSXV | Healthcare | Biotechnology & Medical Research | CAD 4.70M | -3.2x | -0.05 | CAD 1.35 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Appili Therapeutics | Toronto | Healthcare | Biotechnology & Medical Research | CAD 4.24M | -1x | -0.02 | CAD 0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Quest PharmaTech | TSXV | Healthcare | Biotechnology & Medical Research | CAD 4.23M | -2.1x | -0.03 | CAD 0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |